<?xml version="1.0" encoding="ISO-8859-1" ?>
<!-- Do not remove, space added for FireFox bug                                                                                                                                                        
                                                                                                                                                                                                       
                                                                                                                                                                                                       -->
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/rss/rss.xslt"?>
<rss version="2.0" siteURL="https://jobs.soton.ac.uk/" siteName="Recruitment at the University of Southampton" cssPath="/Org/Layout/Css/v43"
  catType="division/prof service" catTypes="divisions/prof services"
  catTitle="Faculty of Medicine" >
  <channel>
    <title>Recruitment at the University of Southampton | Faculty of Medicine</title>
    <link>https://jobs.soton.ac.uk/Vacancies.aspx?cat=1113&amp;type=10</link>
    <description>Latest job vacancies at University of Southampton</description>
    
        <item>
          <title><![CDATA[Research Fellow in Cancer Immunotherapy (3214725A4-R2)]]></title>
          <link>https://jobs.soton.ac.uk/rss/click.aspx?ref=3214725A4-R2</link>
          <guid>https://jobs.soton.ac.uk/rss/click.aspx?ref=3214725A4-R2</guid>
          <description><![CDATA[
            <p id="isPasted"><strong>Project summary</strong></p><p>An exciting opportunity is available to join a multidisciplinary research programme across the laboratories of Dr Salah Mansour, Dr Ali Roghanian and Dr Andres Vallejo at the University of Southampton. We are seeking a collaborative and motivated postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML).</p><p>This three-year project will harness cytotoxic invariant Natural Killer T (iNKT) cells for precision targeting of AML, an aggressive leukaemia with poor survival outcomes. Building on strong preliminary data, it combines mechanistic and translational immunology with bespoke <em>in vivo</em> models to define and exploit therapeutically relevant subsets. The Research Fellow will lead studies on cytotoxic T cell mechanisms, oversee preclinical validation, and advance CAR-iNKT platforms optimised for AML immunotherapy.</p><p>The role bridges basic and translational research and suits a creative scientist with interests in tumour immunology, T cell engineering, and immunotherapy. You will join a multidisciplinary team spanning immunology, and bioinformatics, with access to advanced flow cytometry, 10X Genomics, <em>in vivo</em> imaging platforms.</p><p><strong>Key responsibilities</strong></p><ul type="disc"><li>To work within the Mansour and Roghanian labs, and with collaborators at Southampton and beyond.</li><li>To design, conduct, and analyse <em>in vitro</em> and <em>in vivo</em> immunology experiments.</li><li>To lead the optimisation and functional assessment of human T cells and CAR T cells.</li><li>To liaise and coordinate between project collaborators and core facilities.</li><li>To record analyses accurately and present results at group meetings, national, and international conferences.</li><li>To contribute to dissemination of findings through publications and grant applications.</li><li>To supervise and support junior researchers and students.</li><li>Any other duties appropriate to the scope and grade of the post.</li></ul><p>Postdoctoral Fellows are expected to lead their own projects, collaborate on others, and guide PhD and Master&rsquo;s students.</p><p><strong>Essential qualifications, experience and competencies</strong></p><ul type="disc"><li>PhD (or near completion) in human T cell immunology, cancer biology, or a related discipline.</li><li>Strong practical experience with core immunological assays (e.g. FACS, ELISA, T cell assays).</li><li>Proven competence in the design and execution of experiments using mouse models of cancer.</li><li>Ability to manage projects to timelines, supervise junior staff, and work both independently and collaboratively.</li><li>Excellent communication and presentation skills, including at conferences.</li></ul><p><strong>Desirable</strong></p><ul type="disc"><li>Experience with single-cell or bulk sequencing (e.g. 10X Genomics, RNA-seq).</li><li>Familiarity with bioinformatics pipelines and large dataset interpretation.</li><li>Experience in engineering human T cells, viral transduction, or related approaches.</li><li>Home Office Personal Licence.</li></ul><p><strong>About us</strong></p><p>The University of Southampton offers a strong environment for translational immunology. Clinical and Experimental Sciences (CES) is a hub for infection and immunology, while the Centre for Cancer Immunology (CCI) is the UK&rsquo;s first dedicated cancer immunology centre. Together, they unite expertise in T cell biology, multiomics, immunotherapy, preclinical modelling, and clinical translation, supported by an embedded Clinical Trials Unit and close links with NHS and industry partners.</p><p id="isPasted"><strong>Working at the University of Southampton:</strong></p><p>Check out the <a href="https://www.southampton.ac.uk/hr/services/benefits-explained/index.page">staff benefits</a> and why you should join us at The University of Southampton!</p><p id="isPasted">Applicants should provide:</p><ul type="disc"><li>A CV</li><li>A cover letter outlining suitability for the role</li><li>Contact details for at least two recent referees</li></ul>
            <p>
              Closing Date: 03 May 2026<br />
            </p>
            <p>
              Section: Education, Research &amp; Enterprise
            </p>
            <p>Salary: &#163;36,636 to &#163;44,746 per annum<br/> Full Time Fixed Term until 31/10/2028</p>
          ]]></description>
          <category><![CDATA[Education, Research &amp; Enterprise]]></category>
          <pubDate>Thu, 26 Mar 2026 00:00:00 GMT</pubDate>
        </item>
      
  </channel>
</rss>
